» Medical & Health » Diseases » V01-Y98. External causes of morbidity and martality » Y40-Y84. Complications of medical and surgical care » Y40-Y59. Drugs, medicaments and biological substances causing adverse effects in therapeutic use » Y51. Drugs primarily affecting the autonomic nervous system
|
Y51.0
Anticholinesterase agents
Y51.1
Other parasympathomimetics [cholinergics]
Y51.2
Ganglionic blocking drugs, not elsewhere classified
Y51.3
Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
Papaverine
Y51.4
Predominantly α-adrenoreceptor agonists, not elsewhere classified
Metaraminol
Y51.5
Predominantly β-adrenoreceptor agonists, not elsewhere classified
Excludes: salbutamol (Y55.6)
Y51.6
α-Adrenoreceptor antagonists, not elsewhere classified
Excludes: ergot alkaloids (Y55.O)
Y51.7
β-Adrenoreceptor antagonists, not elsewhere classified
Y51.8
Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
Excludes: clonidine (Y52.5)
guanethidine (Y52.5)
Y51.9
Other and unspecified drugs primarily affecting the autonomic nervous system
Drugs stimulating both α- and β-adrenoreceptors
Write Something Under This Category
|